These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 22703954

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Patent ductus arteriosus management and outcomes in Japan and Canada: comparison of proactive and selective approaches.
    Isayama T, Mirea L, Mori R, Kusuda S, Fujimura M, Lee SK, Shah PS, Neonatal Research Network of Japan and the Canadian Neonatal Network.
    Am J Perinatol; 2015 Sep; 32(11):1087-94. PubMed ID: 25825965
    [Abstract] [Full Text] [Related]

  • 3. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M, Bose C, Clark R.
    J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
    [Abstract] [Full Text] [Related]

  • 4. Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.
    Saldeño YP, Favareto V, Mirpuri J.
    J Perinatol; 2012 Dec; 32(12):953-8. PubMed ID: 22460543
    [Abstract] [Full Text] [Related]

  • 5. Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada.
    Lokku A, Mirea L, Lee SK, Shah PS, Canadian Neonatal Network.
    Am J Perinatol; 2017 Apr; 34(5):441-450. PubMed ID: 27649293
    [Abstract] [Full Text] [Related]

  • 6. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM, Brown E, Mirochnick M, O'Brien S, Kaufman G.
    J Perinatol; 2002 Apr; 22(7):535-40. PubMed ID: 12368968
    [Abstract] [Full Text] [Related]

  • 7. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M, Ohlsson A, Shah S.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD003951. PubMed ID: 18254035
    [Abstract] [Full Text] [Related]

  • 8. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L, Nankervis CA, Delooze D, Giannone PJ.
    J Perinatol; 2007 Mar 23; 27(3):158-63. PubMed ID: 17251986
    [Abstract] [Full Text] [Related]

  • 9. Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study.
    Kang SL, Samsudin S, Kuruvilla M, Dhelaria A, Kent S, Kelsall WA.
    Cardiol Young; 2013 Oct 23; 23(5):711-6. PubMed ID: 23164413
    [Abstract] [Full Text] [Related]

  • 10. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M, Ohlsson A, Shah S.
    Cochrane Database Syst Rev; 2003 Oct 23; (3):CD003951. PubMed ID: 12917997
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M, Clyman RI.
    J Pediatr; 2017 Aug 23; 187():119-126.e1. PubMed ID: 28396025
    [Abstract] [Full Text] [Related]

  • 12. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
    Evans P, O'Reilly D, Flyer JN, Soll R, Mitra S.
    Cochrane Database Syst Rev; 2021 Jan 15; 1(1):CD013133. PubMed ID: 33448032
    [Abstract] [Full Text] [Related]

  • 13. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Linder N, Bello R, Hernandez A, Rosen C, Birk E, Sirota L, Pushkov Y, Klinger G.
    Am J Perinatol; 2010 May 15; 27(5):399-404. PubMed ID: 20013578
    [Abstract] [Full Text] [Related]

  • 14. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.
    Weisz DE, Mirea L, Rosenberg E, Jang M, Ly L, Church PT, Kelly E, Kim SJ, Jain A, McNamara PJ, Shah PS.
    JAMA Pediatr; 2017 May 01; 171(5):443-449. PubMed ID: 28264088
    [Abstract] [Full Text] [Related]

  • 15. [Is it possible to predict the success of pharmacological closure of persistent ductus arteriosus in prematurely born neonates?].
    Fendler W, Bernas S, Jarosik K, Piotrowski A.
    Anestezjol Intens Ter; 2008 May 01; 40(3):156-61. PubMed ID: 19469116
    [Abstract] [Full Text] [Related]

  • 16. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO, Bird TM, King AJ, Ambadwar PB, Jaquiss RD, Kaiser JR, Robbins JM.
    J Neonatal Perinatal Med; 2014 Jan 01; 7(3):229-35. PubMed ID: 25322995
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I, Boubred F, Simeoni U.
    J Matern Fetal Neonatal Med; 2009 Jan 01; 22 Suppl 3():14-20. PubMed ID: 19925358
    [Abstract] [Full Text] [Related]

  • 18. Effects of Milrinone on Neonates after Patent Ductus Arteriosus Ligation: A Retrospective Nationwide Database Study.
    Kitaoka H, Konishi T, Shitara Y, Ito A, Kashima K, Fujita A, Matsui H, Kato M, Takahashi N, Yasunaga H.
    Neonatology; 2023 Jan 01; 120(6):751-759. PubMed ID: 37757762
    [Abstract] [Full Text] [Related]

  • 19. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.
    Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K.
    Arch Dis Child Fetal Neonatal Ed; 2005 May 01; 90(3):F235-9. PubMed ID: 15846015
    [Abstract] [Full Text] [Related]

  • 20. Predictors of PDA Treatment in Preterm Neonates Who Had Received Prophylactic Indomethacin.
    Louis D, ElSayed YN, Ojah C, Alvaro R, Shah PS, Dunn M, Canadian Neonatal Network Investigators.
    Am J Perinatol; 2018 Apr 01; 35(5):509-514. PubMed ID: 29183097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.